Topic:

Emerging Markets

Latest Headlines

Latest Headlines

Ranbaxy to make drugs in Malaysia, Nigeria

Indian genericsmaker Ranbaxy Laboratories is on a bit of an expansion binge.

CMO outsourcing in Asia expected to reach $60B by 2018

A study conducted by GBI Research predicts that CMO outsourcing in Asia will generate $60 billion in revenues by 2018.

Pfizer to grow manufacturing capacity in Indonesia

Pfizer ($PFE) will expand in Indonesia ahead of government plans to offer health insurance for some low-income people.

Canada's Monteris snags $9M in investments for NeuroBlate

Monteris announced it pulled down $9 million in VC investment this month, aimed to support the continued marketing of the company's neurosurgical ablation tech.

Eleven adds $20M in venture cash as it preps for the clinic

Eleven Biotherapeutics has topped up its bank account with a $20 million injection of venture cash and unveiled a look at the company's lead treatment, EBI-005.

Bayer slams Indian government, Cipla on Nexavar copies

Since the Indian government yanked its exclusivity on the cancer drug, the German company is fighting back.

Covance sees early development losses, closes Arizona lab

Despite posting overall financial growth in the first quarter, Covance will eliminate its Chandler, AZ, facility and make cuts to its early development cost structure in an effort to improve profits, the CRO announced.

Abbott, Syngene to open first R&D nutrition center in India

The Abbott Nutrition R&D Center is an effort between Abbott and Syngene to develop nutritional products, while expanding Abbott's nutrition portfolio at the same time.

AMRI gets 'smart' with its contract services

By launching what it calls SmartSourcing, the Albany CRMO hopes to provide clients with insourcing and outsourcing opportunities that lead to high-quality performance and scientific expertise without breaking the bank.

With upgrades, India to reopen 3 vaccine plants

An Indian company known for making condoms has completed upgrades on a vaccine plant there and is nearing completion on two others.